Source:http://linkedlifedata.com/resource/pubmed/id/21160945
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-12-16
|
pubmed:abstractText |
The presence or development of liver metastases in patients with neuroendocrine pancreatic tumors is the most important prognostic factor. Liver resection, transplantation and many different therapeutic approaches are discussed in this special review.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1948-5182
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
27
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
367-73
|
pubmed:year |
2010
|
pubmed:articleTitle |
Liver-specific therapies for metastases of neuroendocrine pancreatic tumors.
|
pubmed:affiliation |
Volker Fendrich, Nils Habbe, Detlef Klaus Bartsch, Department of Surgery, Philipps-University, Marburg D-35043, Germany.
|
pubmed:publicationType |
Journal Article
|